NWM
GILD icon

NEIRG Wealth Management’s Gilead Sciences GILD Stock Holding History

NEIRG Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,908
Closed -$224K – 40
2023
Q2 		$224K Buy
2,908
+67
+2% +$5.34K 0.04% 130
2023
Q1 		$236K Buy
+2,841
New +$235K 0.04% 131
2022
Q1 		– Sell
-10,057
Closed -$730K – 147
2021
Q4 		$730K Buy
+10,057
New +$693K 0.14% 71

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEIRG Wealth Management's GILD Position: Q3 2023 in Review

NEIRG Wealth Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 2,908 shares — an estimated $224K sold.

NEIRG Wealth Management first reported a position in GILD in Q4 2021 and held it in 3 quarters. The position peaked at $730K in Q4 2021. 1,683 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • NEIRG Wealth Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • NEIRG Wealth Management sold 2,908 Gilead Sciences shares in Q3 2023, an estimated $224K.
  • NEIRG Wealth Management first reported a position in Gilead Sciences in Q4 2021 and held it in 3 quarters.
  • NEIRG Wealth Management's Gilead Sciences position peaked at $730K in Q4 2021.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on NEIRG Wealth Management's 13F filing for Q3 2023.